MassMutual Private Wealth & Trust’s Xenon Pharmaceuticals XENE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03K	Hold	17	–	–	﹤0.01%	2169
2026 Q1	$989	Buy	17 +6	+55%	+$276	﹤0.01%	2135
2025 Q4	$493	Buy	+11	New	+$462	﹤0.01%	2239
2025 Q2	–	Sell	-39	Closed	-$1.31K	–	2507
2025 Q1	$1.31K	Buy	+39	New	+$1.48K	﹤0.01%	2045
2024 Q3	–	Sell	-40	Closed	-$1.56K	–	2267
2024 Q2	$1.56K	Buy	+40	New	+$1.6K	﹤0.01%	1712

Other funds holding XENE

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

MassMutual Private Wealth & Trust's XENE Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Xenon Pharmaceuticals (XENE) position steady in Q2 2026 at 17 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

MassMutual Private Wealth & Trust first reported a position in XENE in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.56K in Q2 2024. 58 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

MassMutual Private Wealth & Trust held 17 shares of Xenon Pharmaceuticals worth $1.03K as of Q2 2026.
MassMutual Private Wealth & Trust left its Xenon Pharmaceuticals share count unchanged in Q2 2026.
Xenon Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2169 holding.
MassMutual Private Wealth & Trust first reported a position in Xenon Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
MassMutual Private Wealth & Trust's Xenon Pharmaceuticals position peaked at $1.56K in Q2 2024.
58 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.